← Back to Clinical Trials
Recruiting NCT06134154

NCT06134154 Safety and Efficacy of Carbon Dioxide Gas for Endoscopy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06134154
Status Recruiting
Phase
Sponsor University of Alabama at Birmingham
Condition Abdominal Pain
Study Type INTERVENTIONAL
Enrollment 350 participants
Start Date 2024-01-24
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 6 Months
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Endoscopic insufflation gas

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 350 participants in total. It began in 2024-01-24 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare the efficacy and safety of air versus carbon dioxide gas insufflation for endoscopy in children. The main question\[s\] it aims to answer are: •to determine safety of CO2 Assess patient comfort (abdominal pain, flatulence and bloating) with CO2 use when compared to air.

Eligibility Criteria

Inclusion Criteria: \- Infants and children 6 months to 18 years undergoing any upper endoscopy related procedure including but not limited to EGD/Colonoscopy, ERCP, EGD only, EUS, EGD with foreign body removal, Enteroscopy. Exclusion Criteria: * Patients with American Society of Anesthesiology (ASA) Physical Status Classification System of 4 and above * Children with chronic lung disease, * Children who are wards of the state will be excluded. * Children needing language interpreting services that is not Spanish.

Contact & Investigator

Central Contact

Chinenye R Dike, MD MS

✉ cdike@uabmc.edu

📞 205 638 9918

Frequently Asked Questions

Who can join the NCT06134154 clinical trial?

This trial is open to participants of all sexes, aged 6 Months or older, up to 18 Years, studying Abdominal Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06134154 currently recruiting?

Yes, NCT06134154 is actively recruiting participants. Contact the research team at cdike@uabmc.edu for enrollment information.

Where is the NCT06134154 trial being conducted?

This trial is being conducted at Birmingham, United States.

Who is sponsoring the NCT06134154 clinical trial?

NCT06134154 is sponsored by University of Alabama at Birmingham. The trial plans to enroll 350 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology